| 2024-05-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Scientific Officer | 54 <0.0001% | $430.93 | $23,270 | +7.49% | |
| 2024-02-26 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 4,239 0.0016% | $425.70 | $1.8M | -3.7% | |
| 2024-02-21 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 3,002 0.0012% | $421.77 | $1.27M | -0.31% | |
| 2024-02-20 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 4,002 0.0016% | $420.79 | $1.68M | -0.48% | |
| 2024-02-12 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 3,145 0.0012% | $420.24 | $1.32M | +0.03% | |
| 2023-11-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 19 <0.0001% | $369.92 | $7,028 | +18.93% | |
| 2023-08-09 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 63 <0.0001% | $345.51 | $21,767 | +17.11% | |
| 2023-02-27 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 4,238 0.0016% | $287.51 | $1.22M | +21.88% | |
| 2023-02-21 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 4,002 0.0016% | $293.77 | $1.18M | +19.61% | |
| 2023-02-14 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 6,398 0.0025% | $298.70 | $1.91M | +16.39% | |
| 2023-02-13 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 4,798 0.0019% | $298.90 | $1.43M | +16.78% | |
| 2023-02-06 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 153 <0.0001% | $309.06 | $47,286 | +14.31% | |
| 2023-02-06 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 1,304 0.0005% | $306.00 | $399,022 | +14.31% | |
| 2022-11-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 34 <0.0001% | $308.61 | $10,493 | +11.18% | |
| 2022-11-07 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 1,303 0.0005% | $303.04 | $394,859 | +10.03% | |
| 2022-08-08 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 210 <0.0001% | $293.02 | $61,534 | +5.55% | |
| 2022-07-19 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 4,561 0.0018% | $287.83 | $1.31M | +5.67% | |
| 2022-02-25 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 7,572 0.003% | $230.98 | $1.75M | +25.11% | |
| 2022-02-18 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 4,312 0.0017% | $230.97 | $995,949 | +25.38% | |
| 2022-02-14 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Global Research and CSO | 2,444 0.001% | $232.02 | $567,057 | +24.26% |